# Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)

> **NCT07263958** · NA · NOT_YET_RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Pulmnary Hypertension
- COPD
- Pulmonary Hypertension Secondary to Lung Disease and/or Hypoxia

## Interventions

- **DRUG:** Iloprost is a synthetic molecule with pharmacological action

## Key facts

- **NCT ID:** NCT07263958
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-20
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07263958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07263958, "Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07263958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*